« Previous
Next »
Psychiatry Research: Neuroimaging
Volume 163, Issue 1
, Pages 13-20
, 30 May 2008
Influence of the catechol-O-methyltransferase val158met genotype on amygdala and prefrontal cortex emotional processing in panic disorder
References
- . Region of interest analysis using an SPM toolbox. In: Presented at the 8th International Conference on Functional Mapping of the Human Brain. 2002;Available on CD-ROM in NeuroImage 16, No 2, Abstract 497
- . Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain. American Journal of Human Genetics. 2004;75:807–821
- . Association of the functional V158M catechol-O-methyl-transferase polymorphism with panic disorder in women. International Journal of Neuropsychopharmacology. 2004;7:183–188
- . Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proceedings of the National Academy of Sciences of the United States of America. 2001;98:6917–6922
- . Pictures of Facial Affect. Palo Alto, CA, USA: Consulting Psychologists Press; 1976;
- . Association analysis of MAOA and COMT with neuroticism assessed by peers. Neuropsychiatric Genetics. 2003;120:90–96
- . Genetic origins of anxiety in women: a role for a functional catechol-methyltransferase polymorphism. Psychiatric Genetics. 2003;13:33–41
- . Prefrontocortical dopamine loss in rats delays long-term extinction of contextual conditioned fear, and reduces social interaction without affecting short-term social interaction memory. Neuropsychopharmacology. 2003;28:490–498
- . The amygdala modulates prefrontal cortex activity relative to conditioned fear. Nature. 1999;402:294–296
- . Evidence for a susceptibility locus for panic disorder near the catechol-O-methyltransferase gene on chromosome 22. Biological Psychiatry. 2002;51:591–601
- . Imaging genomics. British Medical Bulletin. 2003;65:259–270
- . Serotonin transporter genetic variation and the response of the human amygdala. Science. 2002;297:400–403
- . The amygdala response to emotional stimuli: a comparison of faces and scenes. Neuroimage. 2002;17:317–323
- . Neocortical modulation of the amygdala response to fearful stimuli. Biological Psychiatry. 2003;53:494–501
- . A susceptibility gene for affective disorders and the response of the human amygdala. Archives of General Psychiatry. 2005;62:146–152
- . Amygdala-prefrontal coupling depends on a genetic variation of the serotonin transporter. Nature Neuroscience. 2005;8:20–21
- . A review and meta-analysis of the genetic epidemiology of anxiety disorders. American Journal of Psychiatry. 2001;158:1568–1578
- . Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics. 1996;6:243–250
- . The role of the mesoprefrontal dopamine neurons in the acquisition and expression of conditioned fear in the rat. Neuroscience. 1999;92:553–564
- . No association between anxiety disorders and catechol-O-methyltransferase polymorphism. Psychiatry Research. 1998;80:145–148
- . Association between the COMT Val158Met polymorphism and propensity to anxiety in an Australian population-based longitudinal study of adolescent health. Psychiatric Genetics. 2005;15:109–115
- . Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system. Brain. 2005;128:1314–1322
- . Anxiety and Parkinson's disease. Journal of Neuropsychiatry and Clinical Neurosciences. 1996;8:383–392
- . Association of the Val158Met catechol-O-methyltransferase genetic polymorphism with panic disorder. Neuropsychopharmacology. 2006;31:2237–2242
- . Association studies of MAO-A, COMT, and 5-HTT genes polymorphisms in patients with anxiety disorders of the phobic spectrum. Psychiatry Research. 2004;128:21–26
- . A functional magnetic resonance imaging study of amygdala and medial prefrontal cortex responses to overtly presented fearful faces in posttraumatic stress disorder. Archives of General Psychiatry. 2005;62:273–281
- . Catechol-O-methyl transferase activity in patients with depressive illness and anxiety states. British Journal of Psychiatry. 1978;132:133–138
- . Bupropion sustained release for panic disorder. Psychopharmacology Bulletin. 2003;37:66–72
- . Catechol-O-methyltransferase val158met genotype affects processing of emotional stimuli in the amygdala and prefrontal cortex. Journal of Neuroscience. 2005;25:836–842
- . COMT polymorphisms and anxiety-related personality traits. Neuropsychopharmacology. 2005;30:2092–20102
- . Common and distinct brain activation to threat and safety signals in social phobia. Neuropsychobiology. 2005;52:163–168
- . Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage. 2002;15:273–289
- . “Panic attacks” in Parkinson's disease. A long-term complication of levodopa therapy. Acta Neurologica Scandinavica. 1993;87:14–18
- . Methylation pharmacogenetics: catechol O-methyltransferase, thiopurine methyltransferase, and histamine N-methyltransferase. Annual Review of Pharmacology and Toxicology. 1999;39:19–52
- . The cross-national epidemiology of panic disorder. Archives of General Psychiatry. 1997;54:305–309
- . SKID-I, Strukturiertes Klinisches Interview für DSM-IV. Göttingen, Germany: Hogrefe; 1997;
- . Catechol O-methyltransferase genetic polymorphism in panic disorder. American Journal of Psychiatry. 2002;159:1785–1787
- . The association between panic disorder and the L/L genotype of catechol-O-methyltransferase. Journal of Psychiatric Research. 2004;38:365–370
- . Threat is in the eye of the beholder: social anxiety and the interpretation of ambiguous facial expressions. Behaviour Research Therapy. 2007;45:839–847
PII: S0925-4927(07)00096-0
doi: 10.1016/j.pscychresns.2007.04.016
© 2007 Elsevier Ireland Ltd. All rights reserved.
« Previous
Next »
Psychiatry Research: Neuroimaging
Volume 163, Issue 1
, Pages 13-20
, 30 May 2008
